Proteasomal degradation of tau protein

Journal of Neurochemistry

Volumn 83, Issue 1, 2002, Pages 176-185

  David, Della C ^a   Layfield, Robert ^a,d   Serpell, Louise ^b   Narain, Yolanda ^a   Goedert, Michel ^c   Spillantini, Maria Grazia ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Alzheimer's disease; Paired helical filament; Proteasome; Tau; Ubiquitin

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; PROTEASOME; TAU PROTEIN; UBIQUITIN;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; COMPLEX FORMATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NERVE DEGENERATION; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION;

ACETYLCYSTEINE; BLOTTING, WESTERN; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MULTIENZYME COMPLEXES; NEUROBLASTOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; PROTEIN ISOFORMS; TAU PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; UBIQUITIN;

EID: 0036789647     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01137.x     Document Type: Article

References (56)

1. Akopian T. N., Kisselev A. F. and Goldberg A. L. (1997) Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J. Biol. Chem. 272, 1791-1798.
2. Bancher C., Grundke-Iqbal I., Iqbal K., Fried V. A., Smith H. T. and Wisniewski H. M. (1991) Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer's disease. Brain. Res. 539, 11-18.
3. Benaroudj N., Tarcsa E., Cascio P. and Goldberg A. L. (2001) The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes. Biochimie 83, 311-318.
4. Bence N. F., Sampat R. M. and Kopito R. R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555.
5. Brooks P., Fuertes G., Murray R. Z., Bose S., Knecht E., Rechsteiner M. C., Hendil K. B., Tanaka K., Dyson J. and Rivett J. (2000) Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346, 155-161.
6. Canu N., Dus L., Barbato C., Ciotto M. T., Brancolini C., Rinaldi A. M., Novak M., Cattaneo A., Bradbury A. and Calissano P. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18, 7061-7074.
7. Carmel G., Mager E. M., Binder L. I. and Kuret J. (1996) The structural basis of Alz50s selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271, 32789-32795.
8. Coux O., Tanaka K. and Goldberg A. L. (1996) Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801-847.
9. Davies K. J. A. (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83, 301-310.
10. Dick L. R., Cruikshank A. A., Destree T., Greiner L., McCormack T. A., Melandri F. D., Nunes S. L., Palombella V. J., Parent L. A., Plamondon L. and Stein R. L. (1997) Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem. 272, 182-188.
11. Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q. and Lee V. M. (2000) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290, 985-989.
12. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
13. Goedert M. (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16, 460-465.
14. Goedert M. and Jakes R. (1990) Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 9, 4225-4230.
15. Goedert M., Crowther R. A. and Spillantini M. G. (1998) Tau mutations cause frontotemporal dementias. Neuron 21, 955-958.
16. Goedert M., Jakes R., Spillantini M. G., Hasegawa M., Smith M. J. and Crowther R. A. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550-553.
17. Goedert M., Spillantini M. G., Jakes R., Rutherford D. and Crowther R. A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
18. Gray D. A. (2001) Damage control: a possible non-proteolytic role for ubiquitin in limiting neurodegeneration. Neuropathol. Appl. Neurobiol. 27, 89-94.
19. Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H. D. and Huber R. (1997) Structure of 20S proteasome from yeast at 2.4A resolution. Nature 386, 437-438.
20. Ishiguro K., Ohno H., Arai H., Yamaguchi H., Urakami K., Park J. M., Sato K., Kohno H. and Imahori K. (1999) Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease. Neurosci. Lett. 270, 91-94.
21. Jahngen-Hodge J., Obin M. S., Gong X., Shang F., Nowell T. R. Jr, Gong J., Abasi H., Blumberg J. and Taylor A. (1997) Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem. 272, 28218-28226.
22. Jariel-Encontre I., Pariat M., Martin F., Carillo S., Salvat C. and Piechaczyk M. (1995) Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26S proteasome. J. Biol. Chem. 270, 11623-11627.
23. Johnson G. V., Seubert P., Cox T. M., Motter R., Brown J. P. and Galasko D. (1997) The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68, 430-433.
24. Keller J. N., Hanni K. B. and Markesbery W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439.
25. Kenessey A., Nacharaju P., Ko L. and Yen S.-H. (1997) Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J. Neurochem. 69, 2026-2038.
26. Kisselev A. F., Akopian T N. and Goldberg A. L. (1998) Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes. J. Biol. Chem. 273, 1982-1989.
27. Kisselev A. F., Akopian T. N., Woo K. M. and Goldberg A. L. (1999) The sizes of the peptides generated from protein by mammalian 26 and 20S proteasomes. J. Biol. Chem. 274, 3363-3371.
28. Kisselev A. F., Kaganovich D. and Goldberg A. L. (2002) Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites for 20S proteasomes. Evidence for peptide-induced channel opening in the the β-rings. J. Biol. Chem. 277, 22260-22270.
29. Layfield R., Alban A., Mayer R. J. and Lowe J. (2001) The ubiquitin protein catabolic disorders. Neuropathol. Appl. Neurobiol. 27, 171-179.
30. Lee V. M., Goedert M. and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
31. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M. J., Jonnalagada S., Chemova T., Dehejia A., Lavedan C., Gasser T., Steinbach P. J., Wilkinson K. D. and Polymeropoulos M. H. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452.
32. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Titani K. and Ihara Y. (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10, 1151-1160.
33. Murakami Y., Matsufuji S., Kameji T., Hayashi S., Igarashi K., Tamura T., Tanaka K. and Ichihara A. (1992) Omithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360, 597-599.
34. Navon A. and Goldberg A. L. (2001) Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome. Mol. Cell 8, 1339-1349.
35. Novak M., Kabat J. and Wischik C. M. (1993) Molecular characterization of the minimal protease-resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 12, 365-370.
36. Nunan J., Shearman M. S., Checler F., Cappai R., Evin G., Beyreuther K., Masters C. L. and Small D. H. (2001) The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur. J. Biochem. 268, 5329-5336.
37. Olesen O. F. (1994) Proteolytic degradation of microtubule associated protein tau by thrombin. Biochem. Biophys. Res. Commun. 201, 716-721.
38. Orian A., Schwartz A. L., Israël A., Whiteside S., Kahana C. and Ciechanover A. (1999) Structural motifs involved in ubiquitin-mediated processing of the NF-κB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain. Mol. Cell. Biol. 19, 3664-3673.
39. Orlowski M. (1990) The multicatalytic proteinase complex, a major extralysosomal proteolytic system. Biochemistry 29, 10289-10297.
40. Palombella V. J., Rando O. J., Goldberg A. L. and Maniatis T. (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78, 773-785.
41. Perez M., Valpuesta J. M., Medina M., Montejo de Garcini E. and Avila J. (1996) Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J. Neurochem. 67, 1183-1190.
42. Pickart C. M. (2000) Ubiquitin in chains. Trends Biochem. Sci. 25, 544-548.
43. Reid B. G., Fenton W. A., Horwich A. L. and Weber-Ban E. U. (2001) ClpA mediates directional translocation of substrate proteins into the ClpP protease. Proc. Natl Acad. Sci. USA 98, 3768-3772.
44. Saigoh K., Wang Y. L., Suh J. G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T. and Wada K. (1999) Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23, 47-51.
45. Schweers O., Schonbrunn-Hanebeck E., Marx A. and Mandelkow E. (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for β-structure. J Biol. Chem. 269, 24290-24297.
46. Shimura H., Hattori N., Kubo Si Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K. and Suzuki T. (2000) Familial Parkinson's disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305.
47. 2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26S proteasomes without ubiquitination. J. Biol. Chem. 275, 20295-20301.
48. Thrower J. S., Hoffman L., Rechsteiner M. and Pickart C. M. (2000) Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102.
49. Tofaris G. K., Layfield R. and Spillantini M. G. (2001) Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509, 22-26.
50. WAF1/CIP1 is a binding site for the C8 α-subunit of the 20S proteasome. EMBO J. 20, 2367-2375.
51. Turner G. C. and Varshavsky A. (2000) Detecting and measuring cotranslational protein degradation in vivo. Science 289, 2117-2120.
52. Voges D., Zwickl P. and Baumeister W. (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68, 1015-1068.
53. Yanagawa H., Chung S. H., Ogawa Y., Sato K., Shibata-Seki T., Masai J. and Ishiguro K. (1998) Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro. Biochemistry 37, 1979-1988.
54. Yang L. S. and Ksiezak-Reding H. (1995) Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem. 233, 9-17.
55. Yewdell J. W. (2001) Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol. 11, 294-297.
56. Zemlan F. P., Rosenberg W. S., Luebbe P. A., Campbell T A., Dean G. E., Weiner N. E., Cohen J. A., Rudick R. A. and Woo D. (1999) Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J. Neurochem. 72, 741-750.